Galectin Therapeutics Market Cap

Galectin Therapeutics has a market cap or net worth of $152.72 million as of April 29, 2026. Its market cap has increased by 79.04% in one year.

Market Cap

152.72M

Enterprise Value

272.72M

1-Year Change

79.04%

Ranking

#4042

Market Cap Chart

Since September 10, 2003, Galectin Therapeutics's market cap has increased from $106.80M to $152.72M, an increase of 43.00%. That is a compound annual growth rate of 1.59%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	152.70M	-43.06%
Dec 31, 2025	268.20M	231.11%
Dec 31, 2024	81.00M	-21.13%
Dec 29, 2023	102.70M	52.83%
Dec 30, 2022	67.20M	-45.28%
Dec 31, 2021	122.80M	-3.99%
Dec 31, 2020	127.90M	-21.39%
Dec 31, 2019	162.70M	15.31%
Dec 31, 2018	141.10M	18.57%
Dec 29, 2017	119.00M	313.19%
Dec 30, 2016	28.80M	-26.53%
Dec 31, 2015	39.20M	-48.96%
Dec 31, 2014	76.80M	-48.11%
Dec 31, 2013	148.00M	352.60%
Dec 31, 2012	32.70M	-55.81%
Dec 30, 2011	74.00M	32.14%
Dec 31, 2010	56.00M	288.89%
Dec 31, 2009	14.40M	234.88%
Dec 31, 2008	4.30M	-84.81%
Dec 31, 2007	28.30M	111.19%
Dec 29, 2006	13.40M	-83.91%
Dec 30, 2005	83.30M	21.96%
Dec 31, 2004	68.30M	-23.94%
Dec 31, 2003	89.80M	-15.92%

View and export this data all the way back to 2003. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Oramed Pharmaceuticals	166.23M
Jyong Biotech	165.34M
Tiziana Life Sciences	160.81M
Molecular Partners AG	159.72M
Agenus	157.05M
ProQR Therapeutics	156.99M
Spero Therapeutics	154.57M
Spruce Biosciences	154.52M

Market Cap Rankings